# TRABECTEDIN
> **ANDA214837** · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA LTD · Approved 2022-08-10
## Drug
- **FDA Application Number:** ANDA214837
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRABECTEDIN
- **Generic name:** Trabectedin
- **Active ingredients:** TRABECTEDIN
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** NATCO PHARMA LTD
- **First approval:** 2022-08-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214837)
---
*MORVS · CC0 1.0*